Literature DB >> 23197815

Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential.

Igor Nazarov1, Jae W Lee, Eric Soupene, Sara Etemad, Derrick Knapik, William Green, Elizaveta Bashkirova, Xiaohui Fang, Michael A Matthay, Frans A Kuypers, Vladimir B Serikov.   

Abstract

We describe human chorionic mesenchymal stem cell (hCMSC) lines obtained from the chorion of human term placenta with high therapeutic potential in human organ pathology. hCMSCs propagated for more than 100 doublings without a decrease in telomere length and with no telomerase activity. Cells were highly positive for the embryonic stem cell markers OCT-4, NANOG, SSEA-3, and TRA-1-60. In vitro, cells could be differentiated into neuron-like cells (ectoderm), adipocytes, osteoblasts, endothelial-like cells (mesoderm), and hepatocytes (endoderm)-derivatives of all three germ layers. hCMSCs effectively facilitated repair of injured epithelium as demonstrated in an ex vivo-perfused human lung preparation injured by Escherichia coli endotoxin and in in vitro human lung epithelial cultures. We conclude that the chorion of human term placenta is an abundant source of multipotent stem cells that are promising candidates for cell-based therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23197815      PMCID: PMC3635148          DOI: 10.5966/sctm.2011-0021

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  34 in total

Review 1.  Placenta--an alternative source of stem cells.

Authors:  Tiina Matikainen; Jarmo Laine
Journal:  Toxicol Appl Pharmacol       Date:  2005-09-01       Impact factor: 4.219

2.  Isolation of amniotic stem cell lines with potential for therapy.

Authors:  Paolo De Coppi; Georg Bartsch; M Minhaj Siddiqui; Tao Xu; Cesar C Santos; Laura Perin; Gustavo Mostoslavsky; Angéline C Serre; Evan Y Snyder; James J Yoo; Mark E Furth; Shay Soker; Anthony Atala
Journal:  Nat Biotechnol       Date:  2007-01-07       Impact factor: 54.908

3.  Isolation and characterization of mesenchymal cells from human fetal membranes.

Authors:  Maddalena Soncini; Elsa Vertua; Lucia Gibelli; Fausto Zorzi; Marco Denegri; Alberto Albertini; Georg S Wengler; Ornella Parolini
Journal:  J Tissue Eng Regen Med       Date:  2007 Jul-Aug       Impact factor: 3.963

Review 4.  Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.

Authors:  Ornella Parolini; Francesco Alviano; Gian Paolo Bagnara; Grozdana Bilic; Hans-Jörg Bühring; Marco Evangelista; Simone Hennerbichler; Bing Liu; Marta Magatti; Ning Mao; Toshio Miki; Fabio Marongiu; Hideaki Nakajima; Toshio Nikaido; C Bettina Portmann-Lanz; Venkatachalam Sankar; Maddalena Soncini; Guido Stadler; Daniel Surbek; Tsuneo A Takahashi; Heinz Redl; Norio Sakuragawa; Susanne Wolbank; Steffen Zeisberger; Andreas Zisch; Stephen C Strom
Journal:  Stem Cells       Date:  2007-11-01       Impact factor: 6.277

5.  Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue.

Authors:  Susanne Wolbank; Anja Peterbauer; Marc Fahrner; Simone Hennerbichler; Martijn van Griensven; Guido Stadler; Heinz Redl; Christian Gabriel
Journal:  Tissue Eng       Date:  2007-06

6.  Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration.

Authors:  C Bettina Portmann-Lanz; Andreina Schoeberlein; Alexander Huber; Ruth Sager; Antoine Malek; Wolfgang Holzgreve; Daniel V Surbek
Journal:  Am J Obstet Gynecol       Date:  2006-03       Impact factor: 8.661

7.  Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta.

Authors:  A Poloni; V Rosini; E Mondini; G Maurizi; S Mancini; G Discepoli; S Biasio; G Battaglini; E Berardinelli; F Serrani; P Leoni
Journal:  Cytotherapy       Date:  2008       Impact factor: 5.414

Review 8.  Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts.

Authors:  C Ferretti; L Bruni; V Dangles-Marie; A P Pecking; D Bellet
Journal:  Hum Reprod Update       Date:  2006-10-26       Impact factor: 15.610

Review 9.  The first molecular details of ALT in human tumor cells.

Authors:  Alessandra Muntoni; Roger R Reddel
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

10.  Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro.

Authors:  Francesco Alviano; Valentina Fossati; Cosetta Marchionni; Mario Arpinati; Laura Bonsi; Michele Franchina; Giacomo Lanzoni; Silvia Cantoni; Claudia Cavallini; Francesca Bianchi; Pier Luigi Tazzari; Gianandrea Pasquinelli; Laura Foroni; Carlo Ventura; Alberto Grossi; Gian Paolo Bagnara
Journal:  BMC Dev Biol       Date:  2007-02-21       Impact factor: 1.978

View more
  23 in total

1.  Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells.

Authors:  Paz L González; Catalina Carvajal; Jimena Cuenca; Francisca Alcayaga-Miranda; Fernando E Figueroa; Jorge Bartolucci; Lorena Salazar-Aravena; Maroun Khoury
Journal:  Stem Cells Transl Med       Date:  2015-08-13       Impact factor: 6.940

Review 2.  High incidence of contaminating maternal cell overgrowth in human placental mesenchymal stem/stromal cell cultures: a systematic review.

Authors:  Celena F Heazlewood; Helen Sherrell; Jennifer Ryan; Kerry Atkinson; Christine A Wells; Nicholas M Fisk
Journal:  Stem Cells Transl Med       Date:  2014-08-25       Impact factor: 6.940

Review 3.  Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

Authors:  Daniel J Weiss
Journal:  Ann Am Thorac Soc       Date:  2013-10

Review 4.  Regenerative therapy for neuronal diseases with transplantation of somatic stem cells.

Authors:  Hiroshi Kanno
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

5.  Study of Bone Marrow and Embryonic Stem Cell-Derived Human Mesenchymal Stem Cells for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice.

Authors:  Qi Hao; Ying-Gang Zhu; Antoine Monsel; Stephane Gennai; Travis Lee; Fengyun Xu; Jae-Woo Lee
Journal:  Stem Cells Transl Med       Date:  2015-05-21       Impact factor: 6.940

6.  Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.

Authors:  Martha L Bustos; Luai Huleihel; Maria G Kapetanaki; Christian L Lino-Cardenas; Lyle Mroz; Bryon M Ellis; Bryan J McVerry; Thomas J Richards; Naftali Kaminski; Nayra Cerdenes; Ana L Mora; Mauricio Rojas
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

7.  Therapeutic effect of placenta-derived mesenchymal stem cells on hypoxic-ischemic brain damage in rats.

Authors:  Hong-Fang Ding; Hui Zhang; Hui-Fang Ding; Dong Li; Xin-Hao Yi; Xin-Yi Gao; Wei-Wei Mou; Xiu-Li Ju
Journal:  World J Pediatr       Date:  2014-12-01       Impact factor: 2.764

8.  Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A(H5N1) Virus-Associated Acute Lung Injury.

Authors:  Hayley Loy; Denise I T Kuok; Kenrie P Y Hui; Miranda H L Choi; W Yuen; John M Nicholls; J S Malik Peiris; Michael C W Chan
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

9.  Mesenchymal Stem/Stromal Cells Derived From a Reproductive Tissue Niche Under Oxidative Stress Have High Aldehyde Dehydrogenase Activity.

Authors:  Gina D Kusuma; Mohamed H Abumaree; Mark D Pertile; Anthony V Perkins; Shaun P Brennecke; Bill Kalionis
Journal:  Stem Cell Rev Rep       Date:  2016-06       Impact factor: 5.739

10.  Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response.

Authors:  Hongfang Ding; Hui Zhang; Huifang Ding; Dong Li; Xinhao Yi; Xiaoxu Ma; Ruijuan Li; Mei Huang; Xiuli Ju
Journal:  Cell Mol Immunol       Date:  2015-12-28       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.